CS logo
small CS logo
Stanford University - Division of Pediatric Stem Cell Transplant & Regenerative Medicine

Palo Alto, California, United States

About Stanford University - Division of Pediatric Stem Cell Transplant & Regenerative Medicine


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Stanford University - Division of Pediatric Stem Cell Transplant & Regenerative Medicine


During the past decade, Stanford University - Division of Pediatric Stem Cell Transplant & Regenerative Medicine conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at Stanford University - Division of Pediatric Stem Cell Transplant & Regenerative Medicine


According to Clinical.Site data, the most researched conditions in "Stanford University - Division of Pediatric Stem Cell Transplant & Regenerative Medicine" are "Acute Lymphoblastic Leukemia" (1 trials), "Anemia, Aplastic" (1 trials), "Cytopenia" (1 trials), "Hemoglobinopathy in Children" (1 trials) and "Hurler Syndrome" (1 trials). Many other conditions were trialed in "Stanford University - Division of Pediatric Stem Cell Transplant & Regenerative Medicine" in a lesser frequency.

Clinical Trials Intervention Types at Stanford University - Division of Pediatric Stem Cell Transplant & Regenerative Medicine


Most popular intervention types in "Stanford University - Division of Pediatric Stem Cell Transplant & Regenerative Medicine" are "Biological" (2 trials) and "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "BPX-501 T cells" (1 trials), "Rimiducid" (1 trials), "rimiducid" (1 trials) and "rivogenlecleucel" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Stanford University - Division of Pediatric Stem Cell Transplant & Regenerative Medicine


The vast majority of trials in "Stanford University - Division of Pediatric Stem Cell Transplant & Regenerative Medicine" are 2 trials for "All" genders.

Clinical Trials Status at Stanford University - Division of Pediatric Stem Cell Transplant & Regenerative Medicine


Currently, there are NaN active trials in "Stanford University - Division of Pediatric Stem Cell Transplant & Regenerative Medicine". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Stanford University - Division of Pediatric Stem Cell Transplant & Regenerative Medicine, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Stanford University - Division of Pediatric Stem Cell Transplant & Regenerative Medicine, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".